Long-term safety of once-daily, dual-release hydrocortisone in patients with adrenal insufficiency: a phase 3b, open-label, extension study.
Nilsson AG, Bergthorsdottir R, Burman P, Dahlqvist P, Ekman B, Engström BE, Ragnarsson O, Skrtic S, Wahlberg J, Achenbach H, Uddin S, Marelli C, Johannsson G.
Nilsson AG, et al. Among authors: johannsson g.
Eur J Endocrinol. 2017 Jun;176(6):715-725. doi: 10.1530/EJE-17-0067. Epub 2017 Mar 14.
Eur J Endocrinol. 2017.
PMID: 28292927
Free PMC article.
Clinical Trial.